Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Cboe UK CHF

Alcon Inc. (ALCZ.XC)

Compare
73.57
-4.85
(-6.19%)
As of 12:52:10 PM GMT+1. Market Open.
Loading Chart for ALCZ.XC
  • Previous Close 78.42
  • Open 76.98
  • Bid 73.58 x --
  • Ask 73.58 x --
  • Day's Range 72.38 - 77.74
  • 52 Week Range 70.96 - 86.09
  • Volume 275,678
  • Avg. Volume 230,257
  • Market Cap (intraday) 36.389B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 40.87
  • EPS (TTM) 1.80
  • Earnings Date --
  • Forward Dividend & Yield 0.24 (0.31%)
  • Ex-Dividend Date May 14, 2024
  • 1y Target Est --

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

www.alcon.com

25,599

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALCZ.XC

View More

Performance Overview: ALCZ.XC

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

ALCZ.XC
4.16%
MSCI WORLD (^990100-USD-STRD)
6.11%

1-Year Return

ALCZ.XC
1.46%
MSCI WORLD (^990100-USD-STRD)
2.41%

3-Year Return

ALCZ.XC
23.26%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

ALCZ.XC
23.26%
MSCI WORLD (^990100-USD-STRD)
96.50%

Compare To: ALCZ.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALCZ.XC

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    38.78B

  • Enterprise Value

    41.68B

  • Trailing P/E

    43.63

  • Forward P/E

    27.55

  • PEG Ratio (5yr expected)

    2.67

  • Price/Sales (ttm)

    4.49

  • Price/Book (mrq)

    2.05

  • Enterprise Value/Revenue

    4.80

  • Enterprise Value/EBITDA

    17.76

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.27%

  • Return on Assets (ttm)

    2.85%

  • Return on Equity (ttm)

    4.83%

  • Revenue (ttm)

    9.91B

  • Net Income Avi to Common (ttm)

    1.02B

  • Diluted EPS (ttm)

    1.80

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.84B

  • Total Debt/Equity (mrq)

    23.85%

  • Levered Free Cash Flow (ttm)

    1.35B

Research Analysis: ALCZ.XC

View More

Company Insights: ALCZ.XC

Research Reports: ALCZ.XC

View More

People Also Watch